✦ LIBER ✦

5.24 Pentostatin, Alemtuzumab, and Low-Dose Rituximab Is Effective Therapy for Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

✍ Scribed by Clive S. Zent; Betsy R. LaPlant; Brian Link; Timothy G. Call; Tait D. Shanafelt; Deborah A. Bowen; Neil E. Kay; George Weiner; Thomas Witzig

Book ID: 119218969
Publisher: Elsevier
Year: 2011
Tongue: English
Weight: 87 KB
Volume: 11
Category: Article
ISSN: 2152-2650
DOI: 10.1016/j.clml.2011.09.178

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

5.27 Low-Dose Fludarabine and Cyclophosp

5.27 Low-Dose Fludarabine and Cyclophosphamide Combined With Rituximab Is a Safe and Effective Treatment Option for Elderly and Comorbid Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Preliminary Results of Project Q-lite, by the Czech CLL Study Group

✍ Lukáš Smolej; Yvona Brychtová; Martin Špaček; Michael Doubek; David Belada; Moni 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 80 KB